BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9545160)

  • 1. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
    Oberg KC
    Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption.
    Havrda DE; Mai T; Chonlahan J
    Pharmacotherapy; 2005 Feb; 25(2):303-7. PubMed ID: 15767245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
    Rao KB; Pallaki M; Tolbert SR; Hornick TR
    Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction.
    Dumo PA; Kielbasa LA
    Pharmacotherapy; 2006 Nov; 26(11):1654-7. PubMed ID: 17064212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremely prolonged INR associated with warfarin in combination with both trazodone and omega-3 fatty acids.
    Jalili M; Dehpour AR
    Arch Med Res; 2007 Nov; 38(8):901-4. PubMed ID: 17923275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
    Lee HL; Kan CD; Yang YJ
    Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin sensitivity after mechanical heart valve replacement.
    Rose JP; Rihn TL; Long SF
    Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranberry does not affect prothrombin time in male subjects on warfarin.
    Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S
    J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
    Hasan SA
    Cornea; 2007 Jul; 26(6):742-3. PubMed ID: 17592328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.